DENVER — Mutations in any of three genes in the JAK family render a common childhood leukemia especially dangerous, researchers reported April 21 at a meeting of the American Association for Cancer Research. The finding may help doctors identify children at high risk of relapse and could ultimately offer a target for drug development, scientists say.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.